Hindustan Construction Company Limited (NSE:HCC)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	46,558	43,440	47,750	20,713	23,754	12,210
Market Cap Growth	-9.03%	-9.03%	130.53%	-12.80%	94.55%	102.26%
Enterprise Value	55,829	59,283	67,673	64,933	30,732	31,646
Last Close Price	25.85	25.85	31.60	13.15	15.07	7.73
PE Ratio	41.34	38.57	9.99	-	4.22	-
PS Ratio	0.83	0.78	0.68	0.25	0.22	0.15
PB Ratio	5.14	4.80	-28.34	-2.90	-3.60	-0.93
P/TBV Ratio	5.48	5.11	-	-	-	-
P/FCF Ratio	-	37.53	66.27	-	2.77	4.47
P/OCF Ratio	-	32.51	52.66	129.45	2.51	3.51
EV/Sales Ratio	1.00	1.06	0.97	0.79	0.29	0.38
EV/EBITDA Ratio	9.68	8.22	10.59	12.87	2.67	8.69
EV/EBIT Ratio	11.73	9.32	11.96	15.44	2.93	11.94
EV/FCF Ratio	48.23	51.21	93.92	-	3.58	11.59
Debt / Equity Ratio	1.85	1.85	-13.19	-7.71	-3.06	-3.62
Debt / EBITDA Ratio	2.28	2.28	3.35	10.30	1.71	12.08
Debt / FCF Ratio	14.51	14.51	30.85	-	2.35	17.49
Asset Turnover	0.65	0.65	0.63	0.60	0.79	0.66
Inventory Turnover	13.32	13.32	11.08	13.11	16.51	13.81
Quick Ratio	1.13	1.13	1.05	0.98	0.65	0.89
Current Ratio	1.21	1.21	1.16	1.09	1.03	0.97
Return on Equity (ROE)	30.55%	30.55%	-	-	-	-
Return on Assets (ROA)	4.63%	4.63%	3.18%	1.92%	4.86%	1.33%
Return on Capital (ROIC)	17.13%	17.13%	10.32%	8.54%	27.23%	4.76%
Return on Capital Employed (ROCE)	19.50%	19.50%	17.90%	6.80%	43.50%	13.20%
Earnings Yield	2.42%	2.59%	10.01%	-1.34%	23.69%	-49.96%
FCF Yield	2.49%	2.67%	1.51%	-9.58%	36.09%	22.37%
Buyback Yield / Dilution	-8.39%	-8.39%	-4.62%	-0.00%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.